ASX:IPD ImpediMed (IPD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About ImpediMed Stock (ASX:IPD) 30 days 90 days 365 days Advanced Chart Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get ImpediMed alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.62 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield3.28%Price TargetN/AConsensus RatingN/A Company OverviewImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.Read More… Receive IPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ImpediMed and its competitors with MarketBeat's FREE daily newsletter. Email Address IPD Stock News Headlines3 ASX Penny Stocks With Market Caps Larger Than A$30MDecember 9, 2024 | uk.finance.yahoo.comWe Think ImpediMed (ASX:IPD) Needs To Drive Business Growth CarefullyDecember 6, 2024 | uk.finance.yahoo.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.December 23, 2024 | Crypto Swap Profits (Ad)ImpediMed Limited Aims to Set New Standard of CareNovember 20, 2024 | markets.businessinsider.comImpediMed Limited Focuses on Commercial Growth StrategyNovember 19, 2024 | markets.businessinsider.comImpediMed Limited’s AGM Resolutions Signal Strategic GrowthNovember 19, 2024 | markets.businessinsider.comImpediMed Limited Showcases Innovations at Bell PotterNovember 18, 2024 | markets.businessinsider.comImpedimed Limited Issues Shares to ExecutivesNovember 4, 2024 | markets.businessinsider.comSee More Headlines IPD Stock Analysis - Frequently Asked Questions What other stocks do shareholders of ImpediMed own? Based on aggregate information from My MarketBeat watchlists, some other companies that ImpediMed investors own include Bardoc Gold (BDC) and Appen (APX). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:IPD CUSIPN/A CIKN/A Webwww.impedimed.com Phone61 7 3860 3700FaxN/AEmployees76Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-102.5Net Income$-19,790,000.00 Net Margins-191.78% Pretax MarginN/A Return on Equity-38.95% Return on Assets-25.96% Debt Debt-to-Equity Ratio2.80 Current Ratio6.33 Quick Ratio6.23 Sales & Book Value Annual Sales$10.32 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.60 Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares2,020,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta2.86 10 Best Stocks to Own in 2025Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio. Get This Free Report This page (ASX:IPD) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImpediMed Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ImpediMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPD Stock Alerts